From Lab Innovation to Life-Saving Therapies: Gene Editing Therapeutics Market Poised to Hit US$ 6.26 Billion by 2032, Expanding at a 147.20% CAGR Driven by Rap…

Rapid advancements in CRISPR and next-generation gene editing technologies, combined with a strong clinical pipeline ...